Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 10, 2018; 90 (15 Supplement) April 25, 2018

The interplay of multiple sclerosis and menstrual cycle: which one affects the other one? (P4.355)

Omid Mimosayyeb, Shervin Badihian, Navid Manouchehri, Vahid Shaygannejad
First published April 9, 2018,
Omid Mimosayyeb
1Isfahan Neurosciences Research Center; Alzahra Research Institute; Isfahan University of Medical Sci Isfahan Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shervin Badihian
1Isfahan Neurosciences Research Center; Alzahra Research Institute; Isfahan University of Medical Sci Isfahan Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Navid Manouchehri
1Isfahan Neurosciences Research Center; Alzahra Research Institute; Isfahan University of Medical Sci Isfahan Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vahid Shaygannejad
1Isfahan Neurosciences Research Center; Alzahra Research Institute; Isfahan University of Medical Sci Isfahan Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
The interplay of multiple sclerosis and menstrual cycle: which one affects the other one? (P4.355)
Omid Mimosayyeb, Shervin Badihian, Navid Manouchehri, Vahid Shaygannejad
Neurology Apr 2018, 90 (15 Supplement) P4.355;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: Here, we aimed to compare the pattern of menstrual cycle and its symptoms between MS patients and healthy controls.

Background: Menstruation is suggested to affect multiple sclerosis (MS) symptoms, while the effect of MS on menstruation is not studied before. Some reports have shown deterioration of MS symptoms in the premenstrual period, while there are results against this finding.

Design/Methods: This is a cross-sectional study conducted during 2015–2016 in MS clinic of Kashani hospital, Isfahan, Iran. We included female patients >14 years with diagnosis of relapsing-remitting MS, and healthy subjects as the control group. We collected data regarding menarche age, menstrual habits, history of premenstrual syndrome, the amount of menstrual bleeding, and the possible symptoms of menstruation from all subjects. Also, MS patients were asked to report changes in menstrual habits after MS occurrence.

Results: The final study population contained 181 MS patients and 202 healthy subjects. The mean age in MS and control group were 36.04±9.86 and 35.16±11.30, respectively (P-value=0.426). Menarche age in MS patients and control group were not statistically different (13.59±1.87and 13.29±1.53, respectively; P-value=0.087). Changing menstrual habits was reported in 44 MS patients (38.6%). Irregular menstrual cycle increased from 21.3% to 40.4% after occurrence of MS (P-value<0.001). Almost all menstrual symptoms were reported more frequently by MS patients before, during, and after menstrual period (P-values<0.001).

Conclusions: We found no difference regarding menstrual habits in MS patients before onset of the disease and healthy controls. Irregular menstrual cycle was observed more after the disease occurrence while other menstrual habits did not change. Moreover, almost all menstrual symptoms were reported more frequently by MS patients during the period.

Disclosure: Dr. Mimosayyeb has received research support from Isfahan Neurosciences Research Center; Alzahra Research Institute; Isfahan University of Medical Sci. Dr. Badihian has nothing to disclose. Dr. Manouchehri has nothing to disclose. Dr. Shaygan Nejad has nothing to disclose.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise